EC
RGEN icon

Elequin Capital’s Repligen RGEN Stock Holding History

Elequin Capital’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$136 Sell
1
-12
-92% -$1.47K ﹤0.01% 653
2026
Q1 		$1.53K Sell
13
-30
-70% -$4.19K ﹤0.01% 511
2025
Q4 		$7.05K Buy
+43
New +$6.74K ﹤0.01% 275
2025
Q1 		– Sell
-61
Closed -$8.78K – 589
2024
Q4 		$8.78K Buy
61
+26
+74% +$3.73K ﹤0.01% 361
2024
Q3 		$5.21K Buy
+35
New +$5.02K ﹤0.01% 288
2024
Q2 		– Sell
-101
Closed -$18.6K – 327
2024
Q1 		$18.6K Buy
+101
New +$19.2K ﹤0.01% 53
2023
Q4 		– Sell
-8
Closed -$1.27K – 470
2023
Q3 		$1.27K Sell
8
-145
-95% -$23.7K ﹤0.01% 322
2023
Q2 		$21.6K Buy
+153
New +$24.5K 0.01% 231
2023
Q1 		– Sell
-7
Closed -$1.19K – 495
2022
Q4 		$1.19K Buy
+7
New +$1.27K ﹤0.01% 593
2022
Q3 		– Sell
-18
Closed -$3K – 655
2022
Q2 		$3K Sell
18
-6
-25% -$949 ﹤0.01% 319
2022
Q1 		$5K Buy
24
+19
+380% +$3.61K ﹤0.01% 216
2021
Q4 		$1K Buy
+5
New +$1.35K ﹤0.01% 47

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Elequin Capital's RGEN Position: Q2 2026 in Review

Elequin Capital reduced its Repligen (RGEN) stake by 92% in Q2 2026, selling an estimated $1.47K and leaving 1 share worth $136. The position accounts for ﹤0.01% of the portfolio, ranked #653.

Elequin Capital first reported a position in RGEN in Q4 2021 and has held it in 12 quarters since. The position peaked at $21.6K in Q2 2023. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Elequin Capital held 1 share of Repligen worth $136 as of Q2 2026.
  • Elequin Capital sold 12 Repligen shares in Q2 2026, an estimated $1.47K.
  • Repligen made up ﹤0.01% of Elequin Capital's portfolio in Q2 2026, its #653 holding.
  • Elequin Capital first reported a position in Repligen in Q4 2021 and has held it in 12 quarters since.
  • Elequin Capital's Repligen position peaked at $21.6K in Q2 2023.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.